Key Messages Q4 / FY Roadshow Season
Portfolio delivering resilience in challenging environment
Delivery on our targets 2020
▪ Adj. EBITDA at €1,906 bn
On spot delivery on guidance already given in May
▪ | FCF at €780 m with improved CCR >40% | ▪ | Next Generation Solutions: ~35% of sales with |
Guidance increased twice, finally above prior-year | products with superior sustainability benefits |
Quality proven across our portfolio
▪ Growth divisions: accounting for ~95% of EBITDA
▪ Innovation Growth Fields: +15% sales growth
Progress on our strategic agenda
▪ Innovation: new RD&I organization implemented
▪ Ongoing portfolio transformation: new divisional structure, acquisitions and carve-out Baby Care
▪ Open & performance-driven corporate culture
Outlook 2021 with clear growth ambition
▪ Adj. EBITDA:
Range of €2.0 bn to €2.3 bn
▪ FCF cash conversion rate: on high prior-year level or around ~40%
Table of contents
1. Evonik at a glance
2. Strategy
3. Financials Q3 2020
4. Appendix
LEADING BEYOND CHEMISTRY
TO IMPROVE LIFE, TODAY AND TOMORROW
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Evonik Industries AG published this content on 10 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 March 2021 08:36:00 UTC.